Kaiser’s Risant adds Integris. Independent systems should reassess options
- Posted by Greg Wahlstrom, MBA, HCM
- Posted in Blog
Kaiser Permanente’s Risant Health has agreed to acquire Integris Health, Oklahoma’s largest nonprofit system, adding a third regional member to a model built on keeping local brands while pooling capital and value-based care capabilities.
The deal
Risant and Integris announced a definitive agreement on Oct. 21. Financial terms were not disclosed, and the transaction still needs regulatory review, with a close possible in early 2027. Integris would keep its name, medical staff, leadership and governing boards, following the pattern Risant set with Geisinger Health and Cone Health.
Integris is a sizable system: about 13,000 employees, 10 acute care and 10 specialty hospitals, and the largest physician network in the state. Its finances explain the timing. For the fiscal year ended June 2025, it reported $3.3 billion in operating revenue and a $22.3 million operating loss. Results improved to roughly break-even in the first nine months of fiscal 2026, but the system had warned of large Medicare and Medicaid revenue losses ahead and planned service and staff reductions.
Why it matters
Risant was created to invest about $5 billion across roughly half a dozen regional systems over five years. Integris shows the kind of partner it is seeking: a large, locally trusted nonprofit with thin margins and rising capital needs. That profile now describes many independent systems facing Medicaid cuts, expensive technology upgrades and payer pressure.
The model also changes the usual merger trade-off. Instead of giving up brand and local governance in exchange for scale, members keep both and gain access to capital, shared platforms and a value-based care playbook. Whether that holds over time is still being tested, but it gives boards another option beyond a traditional acquisition by a larger system.
Questions for boards and executives
- Runway: How many years can we fund capital needs and absorb policy cuts on our own balance sheet?
- Options: Have we compared full mergers, affiliations, joint ventures and models like Risant on governance, capital and mission?
- Timing: Are we evaluating partners while we still have negotiating leverage, or waiting until a downgrade forces the issue?
- Value-based readiness: What would a partner need to see in our data, physician alignment and risk contracts?
Executive takeaway: The strongest negotiating position comes before a crisis. Boards of independent systems should refresh their strategic options review now, with clear criteria for what local control they will and will not trade.